08048036315
Daslemia 50 mg Good Quality Tablet to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Daslemia 50 mg Tablet is an oral oncology medicine containing Dasatinib 50 mg. Dasatinib is a targeted therapy that inhibits specific tyrosine kinases involved in the abnormal growth of certain leukemia cells.

It is a prescription-only medicine and should be used only under the supervision of a qualified oncologist or hematologist.

2. Product Information

  • Brand: Daslemia 50 mg Tablet
  • Active ingredient: Dasatinib 50 mg
  • Dosage form: Oral tablet
  • Therapeutic class: Antineoplastic / tyrosine kinase inhibitor
  • Primary therapeutic area: Hematologic oncology
  • Main conditions: Ph+ CML and Ph+ ALL
  • Manufacturer/Marketer: Intas Pharmaceuticals Ltd. is listed for the product by major Indian medicine references.
  • Typical pack: Product listings commonly show bottles containing 60 tablets, although pack configuration can vary.

3. Uses of Daslemia 50 mg

Daslemia 50 mg is used in the treatment of certain types of leukemia, particularly:

  • Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
  • Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL)

The exact indication and treatment regimen depend on the patient's diagnosis, disease phase, previous treatment and clinical response.

4. Benefits of This Medicine

Daslemia contains dasatinib, which is designed to specifically target abnormal signaling proteins involved in the growth and survival of certain leukemia cells.

Potential therapeutic benefits include:

  • Helps inhibit abnormal leukemia-cell growth.
  • Can slow progression of Ph+ leukemia.
  • Provides targeted treatment against BCR-ABL and related tyrosine kinase activity.
  • May help achieve and maintain disease control when prescribed appropriately.
  • Can be used in certain patients who have resistance or intolerance to previous leukemia treatments.

Important: Benefits vary between patients and should be assessed through regular clinical examinations and laboratory testing.

5. Side Effects of Daslemia 50 mg

Dasatinib can cause side effects. Some may be mild, while others can be serious and require immediate medical attention.

Reported adverse effects include:

  • Fluid retention
  • Pleural effusion
  • Headache
  • Muscle or joint pain
  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Skin rash
  • Fatigue
  • Anemia
  • Reduced platelet count
  • Reduced white blood-cell counts
  • Bleeding
  • Gastrointestinal bleeding
  • Shortness of breath
  • Edema

Serious complications can include pulmonary hypertension, significant fluid accumulation, cardiac complications and severe bleeding.

6. Common Side Effects

Commonly reported effects include:

  1. Headache
  2. Nausea
  3. Vomiting
  4. Diarrhea
  5. Abdominal discomfort
  6. Rash
  7. Fatigue
  8. Muscle pain
  9. Joint pain
  10. Fluid retention or swelling

Patients should inform their doctor if symptoms are persistent, severe or worsening.

7. How to Use Daslemia 50 mg

Daslemia should be taken exactly as prescribed by the treating doctor.

General administration guidance:

  • Take the tablet orally with water.
  • It may generally be taken with or without food.
  • Swallow the tablet whole.
  • Do not crush, chew or break it unless specifically instructed by a healthcare professional.
  • Take it at approximately the same time each day when possible.
  • Do not change the dose or stop treatment without consulting the prescribing physician.

The appropriate dose depends on the leukemia type, treatment history, age and other clinical factors.

8. How Daslemia 50 mg Works

Daslemia contains dasatinib, a tyrosine kinase inhibitor.

Certain leukemia cells contain abnormal proteins, particularly BCR-ABL tyrosine kinase, that send signals encouraging uncontrolled cell growth. Dasatinib inhibits these abnormal kinase signals.

By blocking these signals, dasatinib can reduce the proliferation and survival of leukemia cells and help control the disease.

9. Safety Advice

Daslemia is a potent prescription oncology medicine and requires medical monitoring.

Pregnancy

Dasatinib can cause fetal harm. Women who are pregnant or planning pregnancy should discuss the treatment with their healthcare provider before taking it.

Breastfeeding

Breastfeeding is generally not recommended during treatment with dasatinib; patients should follow their oncologist's advice regarding when breastfeeding can safely resume.

Blood counts

Dasatinib can reduce blood-cell counts. Regular blood tests may therefore be required to monitor white cells, red cells and platelets.

Liver problems

Patients with liver disease should inform their doctor because additional monitoring or treatment adjustments may be required.

Heart and lung problems

Tell the doctor about existing heart or lung conditions. Dasatinib may cause fluid retention, pleural effusion, pulmonary hypertension and other cardiovascular complications.

Drug interactions

Dasatinib has important interactions with several medicines. Patients should provide their doctor with a complete list of prescription medicines, OTC medicines and supplements.

Antacids

Certain antacids can affect dasatinib absorption. Medical references advise separating antacid administration from dasatinib; follow the specific instructions provided by the treating doctor or pharmacist.

Grapefruit

Grapefruit and grapefruit juice may significantly increase dasatinib exposure and should generally be avoided unless the treating physician specifically advises otherwise.

Driving

If dizziness, drowsiness or visual disturbances occur, patients should avoid driving or operating machinery.

10. Frequently Asked Questions (FAQs)

What is Daslemia 50 mg Tablet?

Daslemia 50 mg Tablet is an anti-cancer medicine containing dasatinib 50 mg, used for certain Philadelphia chromosome-positive leukemias.

What is Daslemia 50 mg used for?

It is used for certain cases of Ph+ chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL).

Is Daslemia 50 mg a chemotherapy medicine?

It is an oral targeted anti-cancer therapy and belongs to the tyrosine kinase inhibitor class rather than conventional cytotoxic chemotherapy.

Can Daslemia 50 mg be taken with food?

Yes. Daslemia may generally be taken with or without food, according to prescribing guidance.

Can Daslemia 50 mg be stopped suddenly?

Do not stop dasatinib without consulting the treating oncologist. Treatment duration and discontinuation decisions depend on the individual patient's disease and response.

Does Daslemia require a prescription?

Yes. It is a prescription oncology medicine and should be used under appropriate medical supervision.

Can Daslemia cause low blood counts?

Yes. Dasatinib can cause myelosuppression, including reductions in platelets, red blood cells and white blood cells, so blood-count monitoring may be necessary.

What should I do if I miss a dose?

Follow the missed-dose instructions provided by your oncologist or pharmacist. Do not take an extra dose unless specifically instructed.

11. Substitutes for Daslemia 50 mg

Because Daslemia contains dasatinib 50 mg, potential same-composition alternatives may include brands such as:

  • Dasatrue 50 mg
  • Dasanat 50 mg
  • Dyronib 50 mg
  • Dasania 50 mg
  • Spnib 50 mg
  • Dasather 50 mg

Availability and approved indications can vary by country. A substitute should only be selected by a qualified healthcare professional, particularly for oncology medicines.

12. SEO Keywords

Product Keywords

  • Daslemia 50 mg Tablet
  • Daslemia 50 mg
  • Dasatinib 50 mg Tablet
  • Dasatinib 50mg medicine
  • Dasatinib tablets supplier
  • Daslemia 50 mg exporter
  • Daslemia 50 mg pharmaceutical exporter
  • Dasatinib 50 mg manufacturer India
  • Dasatinib 50 mg supplier India
  • Dasatinib oncology medicine supplier

B2B / Export Keywords

  • Daslemia 50 mg Tablet exporter from India
  • Daslemia 50 mg wholesale supplier India
  • Dasatinib 50 mg wholesale exporter
  • Dasatinib 50 mg bulk medicine supplier
  • Dasatinib 50 mg pharmaceutical distributor
  • Daslemia 50 mg international supplier
  • oncology medicines exporter from Nagpur India
  • anti cancer medicine exporter from India
  • pharmaceutical exporter from Nagpur
  • trusted medicine exporter India
  • pharmaceutical medicine supplier Nagpur India

Country-Focused Keywords

  • Daslemia 50 mg exporter to USA
  • Daslemia 50 mg supplier to UK
  • Dasatinib 50 mg exporter to Australia
  • Dasatinib 50 mg supplier to Singapore
  • Daslemia 50 mg exporter to Canada
  • Dasatinib 50 mg supplier to South Korea
  • Daslemia 50 mg exporter to UAE
  • oncology medicine exporter India to USA UK Australia
  • pharmaceutical exporter India to Canada Singapore UAE
  • Dasatinib supplier India for international markets

Phoenix Exim SEO Keywords

  • Phoenix Exim Daslemia 50 mg supplier
  • Phoenix Exim Dasatinib 50 mg exporter
  • Phoenix Exim pharmaceutical exporter Nagpur
  • Phoenix Exim oncology medicine supplier India
  • Phoenix Exim anti cancer medicine exporter
  • Daslemia 50 mg from Phoenix Exim India
  • Dasatinib 50 mg from Nagpur India
  • trusted pharmaceutical exporter Phoenix Exim
  • Indian medicine exporter for global markets
  • Daslemia 50 mg B2B pharmaceutical supplier
Aug 13th, 2026 3:04 PM

Keywords